MedDataX Logo

Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands

NCT ID: NCT00731536

Last Updated: 2013-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-10-31

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine reports of the cancer called hepatosplenic T-cell lymphoma (HSTCL) in the Dutch National Database of Pathology (Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief or PALGA) during the years 1995 to 2008.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a observational, retrospective (a study in which the participants are identified and then followed backward in time, for the outcome of the study) study. In this study review of all reports of possible cases of hepatosplenic T-cell lymphoma (HSTCL) that were identified within the PALGA database of pathology results for The Netherlands from 1995 to 2008. All patients whose information is contained within the PALGA database were prescribed treatments by a physician on the basis of usual clinical practice or may have received other treatments, including experimental drugs, while participating in an interventional clinical study. The identified data on each of the patients with reports of HSTCL will be collected from the pathologist(s) who prepared the report and from the physician(s) who treated the patient at the time of diagnosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatosplenic T-cell Lymphoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hepatosplenic T-cell Lymphoma Remicade Infliximab Dutch national database of pathology PALGA Autoimmune disease Non-Hodgkin lymphoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Hepatosplenic T-cell Lymphoma (HSTCL)

No intervention

Intervention Type OTHER

This is an observational study. Medical records of patients with the diagnosis of HSTCL in the PALGA database will be analyzed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

This is an observational study. Medical records of patients with the diagnosis of HSTCL in the PALGA database will be analyzed.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patients diagnosed with HSTCL in the Dutch National Database of Pathology (Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief) database during the years 1995 to 2008

Exclusion Criteria

\- Patients who are not diagnosed with HSTCL
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centocor Ortho Biotech Services, L.L.C.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Centocor Ortho Biotech Services, L.L.C. Clinical Trial

Role: STUDY_DIRECTOR

Centocor Ortho Biotech Services, L.L.C.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alkmaar, , Netherlands

Site Status

Amsterdam, , Netherlands

Site Status

Amsterdam-Zuidoost, , Netherlands

Site Status

Eindhoven, , Netherlands

Site Status

Groningen, , Netherlands

Site Status

Nijmegen, , Netherlands

Site Status

Oss, , Netherlands

Site Status

Rotterdam, , Netherlands

Site Status

Utrecht, , Netherlands

Site Status

Winschoten, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C0168Z06

Identifier Type: OTHER

Identifier Source: secondary_id

CR015394

Identifier Type: -

Identifier Source: org_study_id